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Purpose or Objective: 3D printing technology is investigated 
for the purpose of patient immobilization during proton 
therapy. It potentially enables a merge of patient 
immobilization, bolus range shifting/compensator and other 
functions into one single patient-specific structure. Beside 
minimizing the lateral spread of the proton beam due to the 
removal of the air gap it also ensures the correct range 
shifting is present for each beam portal. Compared to a 
movable nozzle snout this reduces the risk of collision and 
treatment time, hence can increase cost-effectiveness of 
proton therapy. In a first step, a set of 3D printed materials 
is characterized, in terms of structural and radiological 
properties, elemental composition, directional dependence 
and structural changes induced by radiation damage. These 
data will serve as input for the design of 3D printed 
immobilization structure prototypes. 
 
Material and Methods: In total 9 materials used in 4 different 
3D printing production techniques were subjected to testing. 
Samples with a nominal dimension of 20x20x80mm were 3D 
printed. The actual dimensions of each printed test object 
were measured with a calliper. The samples were 
compression tested according to a standardized method 
(ASTM D695). The composition in terms of effective atomic 
number (Z_eff) and relative electron density (RED) to water 
was derived from dual-energy CT (DE-CT) data 
(80kVp,Sn140kVp), allowing estimation of the stopping power 
ratio (SPR) to water. Range shifting and directional 
dependence in 3D printed materials were investigated in a 62 
MeV proton beam, using radiochromic film in a Plastic Water 
phantom. 
 
Results: The data of the different experiments are compiled 
in Table 1. Young’s moduli as low as 1 MPa and as high as 
2582 MPa were seen. These experiments will be repeated 
after extensive radiation exposure to verify radiation 
hardness of the structural properties. The DE-CT 
decomposition yielded relative electron densities ranging 
from 0.62 to 1.20, and Z_eff from 6.06 up to 9.35. The 
calculated SPR ranged from 0.69 up to 1.21. The differences 
in range shifts of the obtained Bragg peaks were results of 
differences in SPR, and of deviations from the nominal 20 mm 
thickness due to printing technique geometrical tolerances. 
For 4 out of the 9 materials, a different orientation of the 
sample with respect to the beam incidence resulted in more 
than 5% difference in the obtained range shift. Measurements 
using a Bragg-peak ionization chamber will be included 
allowing a water equivalent thickness measurement 
validation of the material decomposition method with DE-CT. 
 
 
 
Conclusion: 3D printed materials exhibit a wide variation in 
structural and radiological properties. The quantification of 
these characteristics can be used for optimal material 
selection for the design of a 3D printed immobilization 
structure for proton therapy with integrated range shifting. 
 
Proffered Papers: RTT 2: Improving quality for breast 
cancer treatments  
 
 
OC-0165  
Deep inspiration breath hold – can it be detrimental to the 
heart? 
B. Done
1Central Coast Cancer Centre, Radiation Oncology, Gosford, 
Australia 
1, A. Michalski1, A. Windsor1,2 
2University of New South Wales, Faculty of Medicine, 
Randwick, Australia 
 
Purpose or Objective: Deep inspiration breath hold (DIBH) is 
widely used internationally as a standard treatment for left 
sided breast cancer patients.Preliminary results from our 
institution suggest that there is a cohort of patients who have 
an increase in cardiac dose with DIBH compared to free 
breathing (FB). To our knowledge, there are no published 
studies assessing if DIBH can be a detriment in selected 
patients. Our primary objective was to identify patient 
cohorts based on the potential detriment to heart dose 
constraints. The secondary objective was to evaluate 
predictive criteria which would define the degree of benefit 
of DIBH. 
 
Material and Methods: All patients who had left breast or 
chest wall radiotherapy and had both a FB and DIBH CT 
simulation scans at a single institution were selected for this 
study. Planning target volumes (PTV), lung, heart and left 
anterior descending (LAD) artery were contoured on both FB 
and DIBH CT data sets. Both data sets were planned using 
parallel opposed tangents and dynamic wedges. Plans were 
prescribed either 50Gy in 25 fractions or 42.4Gy in 16 
fractions. DIBH plans were considered acceptable for 
treatment delivery where the heart dose constraints were 
reduced, without exceeding lung dose tolerances. Given the 
lack of guidelines on LAD contouring and acceptable dose 
constraints, LAD was contoured and doses recorded for 
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research purposes, but not used for clinical decision making. 
Doses to the PTV, lung, heart and LAD were recorded. Four 
patient groups were identified for comparison: those who had 
at least one heart parameter worse with DIBH, minimal 
benefit arbitrarily defined as less than 20%, moderate benefit 
defined as between 20%-70% and a major benefit defined as 
greater than 70%. 
 
Results: Data was collected for a total of 70 patients. 
Overall, using DIBH, lung volume increased on average by 68% 
(range: 18.5% – 124.3%) while the heart volume in the 
treatment field was reduced by an average 69.5%. The LAD 
volume within the treatment field was reduced by 53%. The 
degree of benefit for heart and LAD doses is outlined in table 
1. 10% had at least one heart parameter worse with DIBH. 
Where the mean heart dose was higher all other heart 
constraints were worse. Five patients had an increase in the 
heart volume and maximum heart distance in the treatment 
field.  
 
 
 
Conclusion: Patients where DIBH was detrimental to heart 
dose constraints, no clear correlation could be drawn to 
identify this cohort of patients. Lung volume or percentage 
increase did not necessarily lead to more favourable 
outcomes, thus could not be used as a criteria for patient 
selection for DIBH. We aim to establish further predictive 
criteria in the second phase of this study. Until such time 
dual planning remains essential to identify patients who 
should not be offered DIBH. 
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Purpose or Objective: To establish whether photon or 
electron beams provide better dose coverage to tumour bed 
sites in different regions of the breast. 
 
Material and Methods: 10 patient data sets were selected 
from a trial cohort, 2 patients each with tumour beds in one 
of 5 regions within the breast – Superior Lateral Quadrant 
(SQL), Superior Medial Quadrant (SMQ), Inferior Lateral 
Quadrant (ILQ), Inferior Medial Quadrant (IMQ) and the 
Central Quadrant. The dose to the whole breast treatment of 
50Gy in 25 fractions was combined with a boost plan to the 
tumour bed of either photons or electrons with a dose of 
16Gy in 8 fractions. Dose to the PTV, lung, heart and breast 
tissues outside the tumour bed were assessed by using DVHs. 
 
Results: Tumours in the SLQ received better dose coverage 
by the photon boost plans. In all other areas of the breast the 
tumour bed coverage objectives were met with either 
photons or electrons.The target coverage in the combined 
plans was at least the same as or better than electrons with 
photon beams in all cases (Figure1). Electron beam coverage 
is dependent on surface contour regularity and tumour 
geometric shape, particularly if the PTV is not perpendicular 
to the skin surface and so requiring higher electron energies 
for PTV coverage at the deep margin. Lung had consistently 
lower doses with photon boost plans as the higher electron 
energies selected for target coverage in some plans increased 
lung dose (Figure2). The breast outside the tumour bed 
received lower doses with photon boosts. The heart doses 
were not consistently lower with either modality. 
 
 
 
Conclusion: Electrons were a less favourable modality for 
SLQ tumours, but either photons or electrons could be 
suitable for treating tumours in other regions of the breast in 
terms of target coverage and organ sparing. As photon boosts 
provided the same as or better coverage than electrons in 
combined plans, it would be feasible to use photons for all 
boosts. However, individualised planning is necessary to 
account for tumour position in relation to normal anatomy, 
surface contour and geometrical shaping of the tumour bed 
to optimise PTV coverage and organ sparing. If using 
electrons particular attention must be paid to the use of 
bolus for beams planned on irregular surface contours. 
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Purpose or Objective: This study was to quantify the 
reduced dose of right lung and right breast tissue by modified 
volumetric modulated arc therapy (MVMAT) for advanced 
left-side breast cancer including lymph node irradiation. 
 
Material and Methods: For all cases, the clinical target 
volume (CTV) consisted of the left breast, axillary lymph 
nodes, internal mammary chain lymph nodes, infraclavicular 
lymph nodes, and supraclavicular lymph nodes. 7 patients of 
MVMAT and 5 patients of volumetric modulated arc therapy 
(VMAT) were generated with the Eclipse Version11 treatment 
planning system. VMAT plans were generated using a five full 
rotation without avoidance sector. MVMAT plans were 
generated using a five partial rotation with avoidance 
sector.Two half arcs were for supraclavicular lymph nodes. 
Gantry angle started at 179 degree, stopped at 335 degree, 
and the 60-120 degree was set to be avoidance sector. 
